NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 50268-0152-15 — cephalexin 500 mg capsuleAI (584 hospitals, 28,481–29,444 samples)
• NDC 00338-1113-04 — Amino acid and dextrose IV nutrition solution with electrolytesAI (394 hospitals, 28,007–29,438 samples)
• NDC 33342-0258-66 — OSELTAMIVIR 75 MG CAPSULEAI (480 hospitals, 28,637–29,429 samples)
• NDC 60687-0224-01 — Gemfibrozil 600 mg tabletsAI (707 hospitals, 28,818–29,421 samples)
• NDC 57237-0041-01 — Penicillin V potassium 500 mg tabletsAI (365 hospitals, 28,805–29,417 samples)
• NDC 70860-0301-25 — Diltiazem hydrochloride 125 mg/25 mL IV solutionAI (301 hospitals, 28,948–29,416 samples)
• NDC 70748-0332-02 — Prednisolone acetate 1% eye drop suspensionAI (252 hospitals, 28,358–29,411 samples)
• NDC 05391-5301-90 — ELEVIEW SUBMUCOSAL INJECTIONAI (60 hospitals, 28,447–29,410 samples)
• NDC 00054-4297-25 — furosemide 20 mg tabletAI (235 hospitals, 28,717–29,401 samples)
• NDC 57664-0377-08 — Tramadol 50 mg tabletsAI (457 hospitals, 28,681–29,392 samples)
• NDC 60687-0593-01 — Hydrochlorothiazide 25 mg tabletAI (660 hospitals, 28,360–29,386 samples)
• NDC 00904-7305-61 — Carvedilol 3.125 mg tabletAI (649 hospitals, 28,453–29,380 samples)
• NDC 00093-1003-01 — BUSPIRONE 15 MG TABLETAI (197 hospitals, 28,756–29,377 samples)
• NDC 47781-0586-29 — Labetalol 5 mg/mL intravenous syringeAI (313 hospitals, 25,807–29,371 samples)
• NDC 00409-3150-20 — Heparin in saline IV solutionAI (178 hospitals, 28,938–29,361 samples)
• NDC 68462-0254-01 — rOPINIRole 0.5 mg tabletAI (311 hospitals, 28,735–29,356 samples)
• NDC 00046-1100-81 — Conjugated estrogens 0.3 mg tabletsAI (744 hospitals, 28,757–29,351 samples)
• NDC 00555-0159-02 — Chlordiazepoxide 25 mg capsulesAI (736 hospitals, 28,645–29,347 samples)
• NDC 00228-2029-10 — ALPRAZolam 0.5 mg tabletAI (431 hospitals, 28,734–29,346 samples)
• NDC 00264-7390-60 — Glycine 1.5% irrigation solutionAI (59 hospitals, 29,244–29,343 samples)
• NDC 81298-7620-01 — Sodium bicarbonate 8.4% intravenous solutionAI (175 hospitals, 28,398–29,343 samples)
• NDC 60505-5307-01 — ACYCLOVIR 800 MG TABLETAI (161 hospitals, 28,733–29,336 samples)
• NDC 00409-7332-11 — Ceftriaxone sodium injection 1 gramAI (514 hospitals, 16,158–29,334 samples)
• NDC 50268-0541-15 — Metoprolol succinate extended-release 50 mg tabletAI (406 hospitals, 28,675–29,332 samples)
• NDC 68462-0904-01 — Posaconazole intravenous solution, 300 mgAI (207 hospitals, 28,593–29,322 samples)
• NDC 51079-0072-20 — Furosemide 20 mg tabletsAI (401 hospitals, 28,674–29,322 samples)
• NDC 67457-0251-02 — Dexmedetomidine injection, 100 mcg/mL, intravenousAI (253 hospitals, 28,835–29,321 samples)
• NDC 50268-0303-15 — FAMOTIDINE 20 MG TABLETAI (214 hospitals, 28,580–29,309 samples)
• NDC 68180-0980-01 — lisinopril 10 mg tabletAI (401 hospitals, 28,640–29,306 samples)
• NDC 60687-0661-01 — Carbidopa-levodopa 25/100 mg tablets, 100-count blister packAI (586 hospitals, 28,672–29,302 samples)
• NDC 51079-0073-20 — Furosemide 40 mg tablets, pack of 100AI (418 hospitals, 28,671–29,292 samples)
• NDC 68462-0331-90 — pramipexole 0.25 mg tabletAI (415 hospitals, 28,671–29,292 samples)
• NDC 47781-0384-26 — Oseltamivir phosphate oral suspension 6 mg/mLAI (397 hospitals, 28,518–29,283 samples)
• NDC 50742-0515-01 — Nitroglycerin 0.3 mg/hr transdermal patchAI (278 hospitals, 28,616–29,282 samples)
• NDC 62756-0520-69 — SUMAtriptan 25 mg tabletAI (282 hospitals, 28,670–29,282 samples)
• NDC 76204-0100-25 — Ipratropium bromide inhalation solutionAI (305 hospitals, 28,365–29,274 samples)
• NDC 00904-5784-61 — Fluoxetine 10 mg capsulesAI (547 hospitals, 28,733–29,273 samples)
• NDC 16729-0090-15 — Finasteride 5 mg tabletsAI (262 hospitals, 28,669–29,272 samples)
• NDC 66689-0401-50 — Oxycodone 5 mg/5 mL oral solution, 5 mL cupAI (289 hospitals, 28,669–29,272 samples)
• NDC 65862-0146-36 — Sumatriptan 25 mg tabletsAI (761 hospitals, 28,505–29,270 samples)
• NDC 00121-2024-10 — lacosamide 10 mg/mL oral solutionAI (148 hospitals, 28,478–29,270 samples)
• NDC 51079-0443-20 — Levothyroxine 125 mcg tablets, 100-count blister packAI (443 hospitals, 28,668–29,262 samples)
• NDC 00487-9801-30 — Ipratropium bromide 0.02% inhalation solutionAI (302 hospitals, 28,363–29,254 samples)
• NDC 31722-0531-01 — torsemide 20 mg tabletAI (385 hospitals, 28,558–29,251 samples)
• NDC 50268-0816-15 — Zonisamide 100 mg capsulesAI (483 hospitals, 28,619–29,249 samples)
• NDC 27241-0097-06 — Duloxetine 20 mg delayed-release capsuleAI (405 hospitals, 28,585–29,242 samples)
• NDC 63323-0130-11 — Doxycycline hyclate 100 mg injection vialAI (985 hospitals, 15,538–29,236 samples)
• NDC 63256-0200-05 — Sterile talc powder, 5 gram vialAI (367 hospitals, 29,087–29,231 samples)
• NDC 42023-0187-01 — Dexmedetomidine IV infusion in salineAI (218 hospitals, 28,429–29,230 samples)
• NDC 00904-6353-61 — Levofloxacin 750 mg tabletAI (784 hospitals, 28,186–29,230 samples)